Clinical trial
Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
NCT00002561 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00002561 |
|---|---|
| Title | Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease |
| Official title | A Phase III Study of Radiotherapy or ABVD Plus Radiotherapy Versus ABVD Alone in the Treatment of Early Stage Hodgkin's Disease |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | Eastern Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hodgkin Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bleomycin sulfate, dacarbazine, doxorubicin hydrochloride, vinblastine, radiation therapy |
| Enrollment | 405 |
| Start date | Jan 25, 1994 |
| Primary completion | Aug 15, 2011 |
| Completion | Jan 6, 2012 |
| First posted | Nov 21, 2003 |
| Last update posted | Apr 14, 2020 |
| Countries | Canada, Italy, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: